Evolution of the Average Target: Medpace Holdings, Inc.

Evolution of the Average Target - Medpace Holdings, Inc.

Evolution of the Target Price: Medpace Holdings, Inc.

Evolution of the Target Price - Medpace Holdings, Inc.

Changes in Analyst Recommendations: Medpace Holdings, Inc.

5d1c6c8.hoNLRudAgVnwYOnjGxB45BKIfuAn1fvWrn3khd6hVYY.99QJLqUn6mC8CcSaTz0du0fnS4JQvba3yxes0pzsEefhwiM1pRblGrkXqA~95da5ba89dd97aaeeb2fd7e547b48a60
10-23 Medpace's Bookings, Pre-Backlog Trends Support Growth Outlook, UBS Says MT
10-23 UBS Adjusts Price Target on Medpace to $700 From $673, Maintains Neutral Rating MT
10-23 Truist Securities Adjusts Price Target on Medpace Holdings to $633 From $609, Keeps Hold Rating MT
10-23 Analyst recommendations: Qiagen, Skydance, Moderna, PG&E, ServiceNow… Zonebourse
10-22 Deutsche Bank Adjusts Medpace Price Target to $650 From $535, Maintains Hold Rating MT
09-30 UBS Upgrades Medpace Holdings to Neutral From Sell, Adjusts Price Target to $673 From $405 MT
08-21 Analyst recommendations: Equifax, Medpace Holdings, Applied Materials, PayPal, Moderna… Zonebourse
07-28 Analyst recommendations: Intuit, AMD, Fortinet, Globe Life… Zonebourse
07-24 Medpace's Bookings Recovery, Normalization of Cancellations Support Growth, RBC Says MT
07-24 Truist Raises Price Target on Medpace Holdings to $609 From $462, Keeps Hold Rating MT
07-24 RBC Raises Price Target on Medpace Holdings to $692 From $484, Keeps Outperform Rating MT
07-24 Analyst recommendations: Netflix, Tapestry, Tesla, AMD, Intel… Zonebourse
07-24 Medpace jumps 15%, order rebound eases fears Zonebourse
07-23 Deutsche Bank Adjusts Medpace Price Target to $535 From $480, Maintains Hold Rating MT
07-08 Medpace Shares Fall After Baird Downgrade MT
07-08 Baird Downgrades Medpace to Neutral From Outperform, Adjusts PT to $547 From $477 MT
07-07 Medpace Shares Fall After Jefferies Downgrade MT
07-07 Jefferies Downgrades Medpace Holdings to Hold From Buy, Adjusts Price Target to $515 From $490 MT
07-07 Analyst recommendations: Ferguson, Medpace, Biogen, Crowdstrike, Take-Two… Zonebourse
04-24 Truist Adjusts Price Target on Medpace to $462 From $539, Maintains Hold Rating MT
04-24 RBC Lowers Price Target on Medpace Holdings to $484 From $522, Keeps Outperform Rating MT
04-23 Deutsche Bank Cuts Price Target on Medpace Holdings to $425 From $480, Keeps Hold Rating MT
03-03 Medpace is Differentiated as Most Efficient Contract Research Organization, RBC Says MT
03-03 RBC Initiates Medpace Holdings at Outperform With $522 Price Target MT
02-18 Medpace Shares Rise After TD Cowen Upgrade MT

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+2.73%
+40.13%
+18.8%
+8.94%
+17.72%
+24.48%
+29.56%
+72.29%
+19.97%
+34.42%
Average +26.90%
Weighted average by Cap. +27.20%


Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
14
Last Close Price
610.54USD
Average target price
651.31USD
Spread / Average Target
+6.68%
High Price Target
730.00USD
Spread / Highest target
+19.57%
Low Price Target
370.00USD
Spread / Lowest Target
-39.40%

Analyst Consensus Detail

Analyst consensus - Medpace Holdings, Inc.

Consensus revision (last 18 months)

Consensus revision (last 18 months) - Medpace Holdings, Inc.
Trader
Investor
Global
Quality
ESG MSCI
A
MarketScreener Ratings - Medpace Holdings, Inc.
  1. Stock Market
  2. Stocks
  3. MEDP Stock
  4. Consensus Medpace Holdings, Inc.